Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma.

Author: Wenqiang YAN ¹ ; Huishou FAN ¹ ; Jingyu XU ¹ ; Jiahui LIU ¹ ; Lingna LI ¹ ; Chenxing DU ¹ ; Shuhui DENG ¹ ; Weiwei SUI ¹ ; Yan XU ¹ ; Dehui ZOU ¹ ; Lugui QIU ¹ ; Gang AN ¹
Author Information

1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Publication Type:Journal Article
MeSH: Humans; Prognosis; Multiple Myeloma/diagnosis*; Neoplasm Staging; Hematopoietic Stem Cell Transplantation; Patients; Retrospective Studies
From: Chinese Medical Journal 2023;136(14):1744-1746
CountryChina
Language:English